Peptide nucleic acid as therapeutic agent


 PNA are synthetic analog of DNA with a repeating N-(2-aminoethyl)-glycine peptide backbone connected to purine and pyrimidine nucleobases via a linker. The unique properties of PNA, including resistance to enzymatic digestion, higher bio stability combined with great hybridization affinity toward DNA and RNA, it has attracted great attention toward PNA- based technology as a promising approach for gene alteration. However, an important challenge in utilizing PNA is poor intracellular uptake. Some strategies have been developed to enhance the delivery of PNA in order to reach cognate site.



 



 


    Related Conference of Peptide nucleic acid as therapeutic agent

    February 22-23, 2023

    International Bio Summit and Expo

    London, UK
    April 17-18, 2023

    13th World Glycobiology Congress

    Rome, Italy
    June 27-28, 2023

    3rd Annual Summit on Advanced Bionics

    Vienna, Austria
    September 21-22, 2023

    19th World Congress on Structural Biology

    Paris, France
    September 21-22, 2023

    14th International Conference on Biofuels and Bioenergy

    Toronto, Canada
    October 23-24, 2023

    27th European Biotechnology Congress

    Rome, Italy
    October 30-31, 2023

    14th World Congress on Cell & Tissue Science

    Rome, Italy

    Peptide nucleic acid as therapeutic agent Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in